CME Group Inc. (CME) Downgraded to Hold at BidaskClub

BidaskClub downgraded shares of CME Group Inc. (NASDAQ:CME) from a buy rating to a hold rating in a report published on Friday, September 1st.

A number of other brokerages have also weighed in on CME. Royal Bank Of Canada increased their price target on CME Group from $130.00 to $135.00 and gave the stock an outperform rating in a research note on Tuesday, June 20th. Deutsche Bank AG reduced their price target on CME Group from $139.00 to $136.00 and set a buy rating on the stock in a research note on Tuesday, July 4th. Keefe, Bruyette & Woods reissued a hold rating and set a $127.00 price target on shares of CME Group in a research note on Friday, August 18th. Jefferies Group LLC reaffirmed a buy rating and issued a $128.00 target price on shares of CME Group in a research report on Monday, July 10th. Finally, Zacks Investment Research lowered CME Group from a hold rating to a sell rating in a research report on Tuesday, July 11th. One analyst has rated the stock with a sell rating, two have issued a hold rating and seven have issued a buy rating to the company. The stock presently has a consensus rating of Buy and an average price target of $132.56.

CME Group (NASDAQ CME) opened at 131.29 on Friday. The stock’s 50 day moving average price is $126.18 and its 200 day moving average price is $122.07. CME Group has a one year low of $98.95 and a one year high of $132.34. The company has a market capitalization of $44.63 billion, a P/E ratio of 26.80 and a beta of 0.72.

CME Group (NASDAQ:CME) last posted its earnings results on Tuesday, August 1st. The financial services provider reported $1.23 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.20 by $0.03. CME Group had a return on equity of 7.61% and a net margin of 46.05%. The firm had revenue of $925.00 million for the quarter, compared to analyst estimates of $931.05 million. During the same quarter in the prior year, the company earned $1.14 EPS. CME Group’s revenue was up 2.1% on a year-over-year basis. Equities analysts anticipate that CME Group will post $4.81 EPS for the current fiscal year.

WARNING: This piece of content was originally reported by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are reading this piece of content on another site, it was illegally stolen and republished in violation of US and international copyright legislation. The correct version of this piece of content can be read at https://ledgergazette.com/2017/09/17/cme-group-inc-cme-lowered-to-hold-at-bidaskclub.html.

The business also recently declared a quarterly dividend, which will be paid on Monday, September 25th. Stockholders of record on Friday, September 8th will be given a dividend of $0.66 per share. The ex-dividend date is Thursday, September 7th. This represents a $2.64 annualized dividend and a dividend yield of 2.01%. CME Group’s payout ratio is 53.99%.

In other CME Group news, CFO John W. Pietrowicz sold 2,500 shares of the firm’s stock in a transaction dated Monday, July 10th. The shares were sold at an average price of $124.50, for a total value of $311,250.00. Following the transaction, the chief financial officer now owns 38,495 shares of the company’s stock, valued at $4,792,627.50. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Ronald A. Pankau sold 300 shares of the firm’s stock in a transaction dated Thursday, August 3rd. The stock was sold at an average price of $124.78, for a total transaction of $37,434.00. Following the completion of the transaction, the director now directly owns 4,009 shares in the company, valued at approximately $500,243.02. The disclosure for this sale can be found here. Insiders have sold 48,244 shares of company stock worth $6,021,890 in the last ninety days. Corporate insiders own 0.57% of the company’s stock.

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Huntington National Bank raised its holdings in shares of CME Group by 4.7% during the first quarter. Huntington National Bank now owns 851 shares of the financial services provider’s stock valued at $100,000 after buying an additional 38 shares during the last quarter. Fiduciary Trust Co. bought a new stake in shares of CME Group during the second quarter valued at approximately $105,000. Coconut Grove Bank raised its holdings in shares of CME Group by 95.7% during the first quarter. Coconut Grove Bank now owns 900 shares of the financial services provider’s stock valued at $107,000 after buying an additional 440 shares during the last quarter. Quadrant Capital Group LLC raised its holdings in shares of CME Group by 13.6% during the second quarter. Quadrant Capital Group LLC now owns 944 shares of the financial services provider’s stock valued at $111,000 after buying an additional 113 shares during the last quarter. Finally, Whittier Trust Co. raised its holdings in shares of CME Group by 12.6% during the first quarter. Whittier Trust Co. now owns 1,030 shares of the financial services provider’s stock valued at $122,000 after buying an additional 115 shares during the last quarter. 82.67% of the stock is currently owned by institutional investors.

CME Group Company Profile

CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.

Analyst Recommendations for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply